A New Commercialization Paradigm for Engaging Today’s HCPs and Improving Business Outcomes
COVID-19 has accelerated the adoption of virtual engagement between brands and healthcare providers (HCPs) across the pharmaceutical industry – but the effectiveness of these engagement strategies was proven repeatedly long before the pandemic.
While it started as an adjunct to traditional commercialization tactics, virtual engagement is now an essential part of an optimal sales strategy and has been core to an inevitable transformation in the pharmaceutical industry.
Download this asset to learn how in improve business outcomes with virtual engagement.
Syneos Health
